<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yue Q</submitter><funding>Natural Science Foundation of Hebei Province</funding><funding>Basic Research Program of Science and Technology in the Education Department of Hebei Province</funding><funding>National Natural Science Foundation of China</funding><pagination>4922</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9370360</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(15)</volume><pubmed_abstract>As a critical molecule in the onset and sustainment of inflammatory response, the receptor for advanced glycation end products (RAGE) has a variety of ligands, such as advanced glycation end products (AGEs), S100/calcium granule protein, and high-mobility group protein 1 (HMGB1). Recently, an increasing number studies have shown that RAGE ligand binding can initiate the intracellular signal cascade, affect intracellular signal transduction, stimulate the release of cytokines, and play a vital role in the occurrence and development of immune-related diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Alzheimer's disease. In addition, other RAGE signaling pathways can play crucial roles in life activities, such as inflammation, apoptosis, autophagy, and endoplasmic reti</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.</pubmed_title><pmcid>PMC9370360</pmcid><funding_grant_id>No. 82003404</funding_grant_id><funding_grant_id>H2019209576</funding_grant_id><funding_grant_id>JQN2019012</funding_grant_id><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Yue Q</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.</name><description>As a critical molecule in the onset and sustainment of inflammatory response, the receptor for advanced glycation end products (RAGE) has a variety of ligands, such as advanced glycation end products (AGEs), S100/calcium granule protein, and high-mobility group protein 1 (HMGB1). Recently, an increasing number studies have shown that RAGE ligand binding can initiate the intracellular signal cascade, affect intracellular signal transduction, stimulate the release of cytokines, and play a vital role in the occurrence and development of immune-related diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Alzheimer's disease. In addition, other RAGE signaling pathways can play crucial roles in life activities, such as inflammation, apoptosis, autophagy, and endoplasmic reti</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T08:01:33.761Z</modification><creation>2025-04-04T08:01:33.761Z</creation></dates><accession>S-EPMC9370360</accession><cross_references><pubmed>35956875</pubmed><doi>10.3390/molecules27154922</doi></cross_references></HashMap>